Eurofins Scient (OTCMKTS:ERFSF) Sees Strong Trading Volume – Still a Buy?

Eurofins Scient (OTCMKTS:ERFSF) saw strong trading volume on Monday . 2,351 shares traded hands during mid-day trading, an increase of 107% from the previous session’s volume of 1,138 shares.The stock last traded at $79.03 and had previously closed at $73.2960.

Analyst Upgrades and Downgrades

ERFSF has been the subject of a number of research reports. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Eurofins Scient in a research note on Wednesday, October 29th. Citigroup reaffirmed a “neutral” rating on shares of Eurofins Scient in a research note on Wednesday, October 22nd. Finally, BNP Paribas raised Eurofins Scient to an “outperform” rating in a research note on Monday. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Hold”.

Eurofins Scient Trading Down 0.8%

The company has a quick ratio of 1.19, a current ratio of 1.26 and a debt-to-equity ratio of 0.77. The firm’s fifty day moving average is $70.50 and its two-hundred day moving average is $73.01.

Eurofins Scient Company Profile

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.